prismCDX, based on its innovative technology and scientific expertise, aims to provide solutions for the appropriate immunotherapy for individual patients. Recently, anticancer immunotherapy has helped to cure cancer successfully. However, anticancer immunotherapy requires analytical methods to comprehensively understand the complexity of the cellular level in the tumor microenvironment because treatment prognosis may vary depending on cancer, immune cells, biomarkers, and biological environment. prismCDX’s immune monitoring technology will help you fully understand the patient’s immune status and apply the right medication to the individual patient. prismCDX is committed to the growth of global healthcare by developing technologies for diagnosis and companion diagnosis with unique technology.